Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.2. Removed references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.1.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.1 was added, and Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.0 were removed.SummaryDifference0.1%

- Check66 days agoChange DetectedUI text updates include added options to show or hide the glossary, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Old items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a new revision label v3.3.4 replacing v3.3.3; no substantive study information was altered.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.